New Zealand markets closed

Cullinan Therapeutics, Inc. (CGEM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.09+0.59 (+3.58%)
At close: 04:00PM EDT
17.09 0.00 (0.00%)
After hours: 05:17PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
98,434
156,152
59,774
168,198
Other short-term investments
368,633
311,140
230,692
42,008
Total cash
467,067
467,292
290,466
210,206
Other current assets
13,124
7,180
6,098
2,072
Total current assets
480,191
474,472
296,564
212,278
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,884
5,439
309
309
Accumulated depreciation
-352
-135
-232
-179
Net property, plant and equipment
3,532
5,304
77
130
Equity and other investments
0
80,882
140,397
0
Other long-term assets
459
459
147
2,300
Total non-current assets
3,991
86,645
140,621
2,430
Total assets
484,182
561,117
437,185
214,708
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
178
-
-
Accounts payable
2,493
2,660
3,169
9,679
Taxes payable
0
4,282
0
-
Accrued liabilities
8,434
7,486
5,028
2,878
Other current liabilities
914
1,955
973
-
Total current liabilities
28,137
22,498
11,746
14,320
Non-current liabilities
Total non-current liabilities
2,150
3,590
65
74
Total liabilities
30,287
26,088
11,811
14,394
Stockholders' equity
Common stock
4
5
4
3
Retained earnings
-200,857
-47,695
-158,909
-93,339
Accumulated other comprehensive income
-129
-2,601
-838
-2
Total stockholders' equity
453,703
535,029
424,971
199,010
Total liabilities and stockholders' equity
484,182
561,117
437,185
214,708